company background image
COLO B logo

Coloplast CPSE:COLO B Voorraadrapport

Laatste prijs

DKK 896.40

Marktkapitalisatie

DKK 201.5b

7D

1.9%

1Y

22.9%

Bijgewerkt

18 Oct, 2024

Gegevens

Financiële gegevens bedrijf +

Coloplast A/S

CPSE:COLO B Voorraadrapport

Marktkapitalisatie: DKK 201.5b

De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

COLO B Overzicht aandelen

Coloplast A/S houdt zich bezig met de ontwikkeling en verkoop van producten en diensten voor de intieme gezondheidszorg in Denemarken, de Verenigde Staten, het Verenigd Koninkrijk, Frankrijk en internationaal.

Over het bedrijf

COLO B fundamentele analyse
Sneeuwvlok Score
Waardering3/6
Toekomstige groei2/6
Prestaties in het verleden2/6
Financiële gezondheid1/6
Dividenden3/6

Beloningen

Verhandeld tegen 39.7% onder onze schatting van de reële waarde
De winst zal naar verwachting met 13.09% per jaar groeien
De winst is de afgelopen 5 jaar met 4.8% per jaar gegroeid

Risicoanalyse

De schulden worden niet goed gedekt door de operationele kasstroom
Het dividend van 2.4% wordt niet goed gedekt door de winst of de vrije kasstromen

Coloplast A/S Concurrenten

Demant

CPSE:DEMANT

DKK 58.6b

Ambu

CPSE:AMBU B

DKK 34.5b

Cooper Companies

NasdaqGS:COO

US$21.3b

Embla Medical hf

CPSE:EMBLA

DKK 14.4b

Prijsgeschiedenis en prestaties

Overzicht van alle hoogtepunten, veranderingen en prijsdalingen voor Coloplast
Historische aandelenkoersen
Huidige aandelenkoersDKK 896.40
52 Week HoogtepuntDKK 977.60
52 Week LaagDKK 689.20
Bèta0.33
11 maand verandering-1.62%
3 maanden verandering4.52%
1 Jaar Verandering22.90%
33 jaar verandering-15.19%
5 jaar verandering12.50%
Verandering sinds IPO6,915.31%

Recent nieuws en updates

Coloplast (CPH:COLO B) Seems To Use Debt Quite Sensibly

Oct 18
Coloplast (CPH:COLO B) Seems To Use Debt Quite Sensibly

Coloplast A/S Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Aug 23
Coloplast A/S Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Recent updates

Coloplast (CPH:COLO B) Seems To Use Debt Quite Sensibly

Oct 18
Coloplast (CPH:COLO B) Seems To Use Debt Quite Sensibly

Coloplast A/S Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Aug 23
Coloplast A/S Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Are Investors Undervaluing Coloplast A/S (CPH:COLO B) By 38%?

Aug 22
Are Investors Undervaluing Coloplast A/S (CPH:COLO B) By 38%?

Subdued Growth No Barrier To Coloplast A/S' (CPH:COLO B) Price

Jul 17
Subdued Growth No Barrier To Coloplast A/S' (CPH:COLO B) Price

These 4 Measures Indicate That Coloplast (CPH:COLO B) Is Using Debt Reasonably Well

Jun 29
These 4 Measures Indicate That Coloplast (CPH:COLO B) Is Using Debt Reasonably Well

Coloplast's (CPH:COLO B) Solid Earnings May Rest On Weak Foundations

May 21
Coloplast's (CPH:COLO B) Solid Earnings May Rest On Weak Foundations

Coloplast (CPH:COLO B) Is Due To Pay A Dividend Of DKK5.00

May 10
Coloplast (CPH:COLO B) Is Due To Pay A Dividend Of DKK5.00

Analyst Estimates: Here's What Brokers Think Of Coloplast A/S (CPH:COLO B) After Its Interim Report

May 09
Analyst Estimates: Here's What Brokers Think Of Coloplast A/S (CPH:COLO B) After Its Interim Report

A Look At The Fair Value Of Coloplast A/S (CPH:COLO B)

Apr 26
A Look At The Fair Value Of Coloplast A/S (CPH:COLO B)

There's Reason For Concern Over Coloplast A/S' (CPH:COLO B) Price

Apr 08
There's Reason For Concern Over Coloplast A/S' (CPH:COLO B) Price

Is Coloplast (CPH:COLO B) A Risky Investment?

Mar 21
Is Coloplast (CPH:COLO B) A Risky Investment?

Estimating The Intrinsic Value Of Coloplast A/S (CPH:COLO B)

Jan 09
Estimating The Intrinsic Value Of Coloplast A/S (CPH:COLO B)

Coloplast A/S' (CPH:COLO B) Price Is Out Of Tune With Earnings

Dec 22
Coloplast A/S' (CPH:COLO B) Price Is Out Of Tune With Earnings

These 4 Measures Indicate That Coloplast (CPH:COLO B) Is Using Debt Reasonably Well

Dec 04
These 4 Measures Indicate That Coloplast (CPH:COLO B) Is Using Debt Reasonably Well

Coloplast (CPH:COLO B) Strong Profits May Be Masking Some Underlying Issues

Nov 16
Coloplast (CPH:COLO B) Strong Profits May Be Masking Some Underlying Issues

A Look At The Intrinsic Value Of Coloplast A/S (CPH:COLO B)

Sep 30
A Look At The Intrinsic Value Of Coloplast A/S (CPH:COLO B)

Is Coloplast (CPH:COLO B) A Risky Investment?

Jun 28
Is Coloplast (CPH:COLO B) A Risky Investment?

Coloplast A/S' (CPH:COLO B) Intrinsic Value Is Potentially 18% Below Its Share Price

Jun 10
Coloplast A/S' (CPH:COLO B) Intrinsic Value Is Potentially 18% Below Its Share Price

Coloplast (CPH:COLO B) Seems To Use Debt Quite Sensibly

Mar 22
Coloplast (CPH:COLO B) Seems To Use Debt Quite Sensibly

Coloplast A/S' (CPH:COLO B) Intrinsic Value Is Potentially 25% Below Its Share Price

Mar 01
Coloplast A/S' (CPH:COLO B) Intrinsic Value Is Potentially 25% Below Its Share Price

These 4 Measures Indicate That Coloplast (CPH:COLO B) Is Using Debt Reasonably Well

Dec 14
These 4 Measures Indicate That Coloplast (CPH:COLO B) Is Using Debt Reasonably Well

Coloplast's (CPH:COLO B) Upcoming Dividend Will Be Larger Than Last Year's

Nov 26
Coloplast's (CPH:COLO B) Upcoming Dividend Will Be Larger Than Last Year's

Here's Why We Think Coloplast A/S' (CPH:COLO B) CEO Compensation Looks Fair for the time being

Nov 25
Here's Why We Think Coloplast A/S' (CPH:COLO B) CEO Compensation Looks Fair for the time being

Coloplast's (CPH:COLO B) Shareholders Will Receive A Bigger Dividend Than Last Year

Nov 11
Coloplast's (CPH:COLO B) Shareholders Will Receive A Bigger Dividend Than Last Year

With EPS Growth And More, Coloplast (CPH:COLO B) Makes An Interesting Case

Oct 25
With EPS Growth And More, Coloplast (CPH:COLO B) Makes An Interesting Case

Estimating The Fair Value Of Coloplast A/S (CPH:COLO B)

Aug 26
Estimating The Fair Value Of Coloplast A/S (CPH:COLO B)

These 4 Measures Indicate That Coloplast (CPH:COLO B) Is Using Debt Reasonably Well

Jul 27
These 4 Measures Indicate That Coloplast (CPH:COLO B) Is Using Debt Reasonably Well

Here's Why We Think Coloplast (CPH:COLO B) Is Well Worth Watching

Jul 12
Here's Why We Think Coloplast (CPH:COLO B) Is Well Worth Watching

Is There An Opportunity With Coloplast A/S' (CPH:COLO B) 45% Undervaluation?

May 23
Is There An Opportunity With Coloplast A/S' (CPH:COLO B) 45% Undervaluation?

Coloplast (CPH:COLO B) Is Due To Pay A Dividend Of kr.5.00

May 08
Coloplast (CPH:COLO B) Is Due To Pay A Dividend Of kr.5.00

Coloplast (CPH:COLO B) Seems To Use Debt Rather Sparingly

Apr 13
Coloplast (CPH:COLO B) Seems To Use Debt Rather Sparingly

Here's Why I Think Coloplast (CPH:COLO B) Is An Interesting Stock

Mar 29
Here's Why I Think Coloplast (CPH:COLO B) Is An Interesting Stock

Coloplast A/S (CPH:COLO B) Shares Could Be 41% Below Their Intrinsic Value Estimate

Feb 12
Coloplast A/S (CPH:COLO B) Shares Could Be 41% Below Their Intrinsic Value Estimate

Coloplast (CPH:COLO B) Could Easily Take On More Debt

Jan 12
Coloplast (CPH:COLO B) Could Easily Take On More Debt

Is Now The Time To Put Coloplast (CPH:COLO B) On Your Watchlist?

Dec 28
Is Now The Time To Put Coloplast (CPH:COLO B) On Your Watchlist?

Rendement voor aandeelhouders

COLO BDK Medical EquipmentDK Markt
7D1.9%1.9%-0.9%
1Y22.9%22.8%19.7%

Rendement versus industrie: COLO B kwam overeen met de Danish Medical Equipment industrie, die het afgelopen jaar een rendement opleverde van 23.8 %.

Rendement versus markt: COLO B overtrof de Danish markt, die het afgelopen jaar een rendement opleverde van 15 %.

Prijsvolatiliteit

Is COLO B's price volatile compared to industry and market?
COLO B volatility
COLO B Average Weekly Movement3.0%
Medical Equipment Industry Average Movement5.6%
Market Average Movement4.2%
10% most volatile stocks in DK Market8.9%
10% least volatile stocks in DK Market2.4%

Stabiele aandelenkoers: COLO B heeft de afgelopen 3 maanden geen significante prijsvolatiliteit gekend.

Volatiliteit in de loop van de tijd: De wekelijkse volatiliteit ( 3% ) van COLO B is het afgelopen jaar stabiel geweest.

Over het bedrijf

OpgerichtWerknemersCEOWebsite
195416,019Kristian Villumsenwww.coloplast.com

Coloplast A/S houdt zich bezig met de ontwikkeling en verkoop van producten en diensten voor de intieme gezondheidszorg in Denemarken, de Verenigde Staten, het Verenigd Koninkrijk, Frankrijk en internationaal. Het bedrijf is actief in de segmenten Chronische zorg, Continentiezorg, Stem- en ademhalingszorg, Interventionele Urologie en Geavanceerde wondzorg. Het bedrijf levert producten voor stomazorg, waaronder SenSura Mio, dat individuele lichaamsvormen en optimale discretie biedt voor verschillende soorten stomazorg; en SenSura Ostomy care solutions, evenals stomazorgaccessoires onder het merk Brava.

Coloplast A/S Samenvatting

Hoe verhouden de winst en inkomsten van Coloplast zich tot de beurswaarde?
COLO B fundamentele statistieken
MarktkapitalisatieDKK 201.55b
Inkomsten(TTM)DKK 4.97b
Inkomsten(TTM)DKK 26.30b

40.6x

Koers/Winstverhouding

7.7x

P/S-verhouding

Is COLO B overgewaardeerd?

Zie Reële waarde en waarderingsanalyse

Inkomsten en omzet

Belangrijkste winstgevendheidsstatistieken uit het laatste winstverslag (TTM)
COLO B resultatenrekening (TTM)
InkomstenDKK 26.30b
Kosten van inkomstenDKK 8.54b
BrutowinstDKK 17.76b
Overige uitgavenDKK 12.79b
InkomstenDKK 4.97b

Laatst gerapporteerde inkomsten

Jun 30, 2024

Volgende inkomensdatum

Nov 05, 2024

Winst per aandeel (EPS)22.09
Brutomarge67.52%
Nettowinstmarge18.88%
Schuld/Eigen Vermogen Verhouding142.3%

Hoe presteerde COLO B op de lange termijn?

Bekijk historische prestaties en vergelijking

Dividenden

2.3%

Huidig dividendrendement

95%

Uitbetalingsratio